NME
NVO

Notis-McConarty Edward’s Novo Nordisk NVO Stock Holding History

Notis-McConarty Edward’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,525
Closed -$1.14M – 75
2025
Q3 		$1.14M Buy
20,525
+1,575
+8% +$92.2K 0.53% 41
2025
Q2 		$1.31M Buy
18,950
+14,540
+330% +$989K 0.64% 38
2025
Q1 		$306K Buy
+4,410
New +$364K 0.16% 61
2024
Q4 		– Sell
-2,300
Closed -$274K – 85
2024
Q3 		$274K Sell
2,300
-300
-12% -$40K 0.12% 77
2024
Q2 		$371K Sell
2,600
-400
-13% -$53K 0.15% 72
2024
Q1 		$385K Sell
3,000
-320
-10% -$38.1K 0.15% 74
2023
Q4 		$343K Sell
3,320
-180
-5% -$17.8K 0.14% 76
2023
Q3 		$318K Sell
3,500
-300
-8% -$26.4K 0.13% 81
2023
Q2 		$307K Sell
3,800
-200
-5% -$16.3K 0.12% 83
2023
Q1 		$318K Hold
4,000
– – 0.13% 83
2022
Q4 		$271K Sell
4,000
-400
-9% -$23.5K 0.11% 89
2022
Q3 		$219K Hold
4,400
– – 0.1% 93
2022
Q2 		$245K Sell
4,400
-400
-8% -$22.2K 0.1% 92
2022
Q1 		$267K Hold
4,800
– – 0.1% 97
2021
Q4 		$269K Sell
4,800
-200
-4% -$10.8K 0.09% 95
2021
Q3 		$240K Buy
+5,000
New +$242K 0.09% 96
2015
Q4 		– Sell
-6,000
Closed -$163K – 106
2015
Q3 		$163K Hold
6,000
– – 0.12% 102
2015
Q2 		$164K Buy
6,000
+1,000
+20% +$28.1K 0.11% 109
2015
Q1 		$133K Hold
5,000
– – 0.09% 111
2014
Q4 		$106K Hold
5,000
– – 0.07% 114
2014
Q3 		$119K Hold
5,000
– – 0.08% 113
2014
Q2 		$115K Hold
5,000
– – 0.08% 108
2014
Q1 		$114K Buy
5,000
+1,000
+25% +$21.3K 0.08% 100
2013
Q4 		$74K Buy
+4,000
New +$69.7K 0.05% 106

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Notis-McConarty Edward's NVO Position: Q4 2025 in Review

Notis-McConarty Edward sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 20,525 shares — an estimated $1.14M sold.

Notis-McConarty Edward first reported a position in NVO in Q4 2013 and held it in 24 quarters. The position peaked at $1.31M in Q2 2025. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Notis-McConarty Edward reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Notis-McConarty Edward sold 20,525 Novo Nordisk shares in Q4 2025, an estimated $1.14M.
  • Notis-McConarty Edward first reported a position in Novo Nordisk in Q4 2013 and held it in 24 quarters.
  • Notis-McConarty Edward's Novo Nordisk position peaked at $1.31M in Q2 2025.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Notis-McConarty Edward's 13F filing for Q4 2025, filed 17 Feb 2026.